Skip to content

Author

Yu-Yue Deng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

PF chemotherapy combined with a PD-1/CTLA-4 bispecific antibody as first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma: a prospective, single-arm, phase II clinical study

This study evaluated the antitumor activity and safety of cadonilimab, a programmed cell death protein 1 (PD-1)/cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) bispecific antibody, combined with platinum/carboplatin and 5-fluorouracil (PF) chemotherapy as first-line treatment for patients with recurrent or met...

Wen-Jun Liao, Qiao-Hua Li, Yu-Yue Deng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.